Data / Form D filings / Infinity Bio, Inc.
Infinity Bio, Inc.: Form D filings
Infinity Bio, Inc., a health care company in Baltimore, MD, filed 4 Form D notices with the SEC between 2023 and 2025. The latest, on August 20, 2025, reports $5 million sold of a $7 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6200 SEAFORTH ST., Baltimore, MD, 21224
- Phone
- (941) 586-9188
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- United States
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1982572
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 20, 2025 | New notice | $7,000,000 | $5,000,000 | $2,000,000 | 1 | Jun 13, 2025 | sec.gov |
| Mar 11, 2025 | New notice | $5,000,000 | $2,000,000 | $3,000,000 | 2 | Feb 18, 2025 | sec.gov |
| Jun 3, 2024 | Amendment | $4,516,093 | $4,516,093 | 1 | Jun 16, 2023 | sec.gov | |
| Jun 26, 2023 | New notice | $4,000,000 | $2,500,000 | $1,500,000 | 1 | Jun 16, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bill Benjamin Campbell | Director | |
| Caroline Popper | Director | |
| Malek Benjamin Fahem | Director | |
| H. Benjamin Larman | Executive Officer, Director | |
| Herman Benjamin Scholtz | Director | |
| Matthew Benjamin Hellauer | Director | |
| Joy Nassif | Executive Officer, Director |
Other health care companies in Maryland that filed recently
- ColoWatch, Inc. /MD/ $1.3 million · Oct 19, 2026
- Aromha, Inc. $75,000 · Sep 24, 2026
- Functional Longevity Labs, Inc. $25,000 · Sep 21, 2026
- Terrace Systems, Inc. $250,000 · Sep 16, 2026
- Savannah Therapeutics, Inc $3.9 million · Sep 11, 2026
- Featherglass Health, Inc. $25,000 · Sep 4, 2026
Every Form D from the week of Aug 18, 2025 · All recent filings in Maryland · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Infinity Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.